Nuveen, LLC Foghorn Therapeutics Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Nuveen, LLC holds 60,438 shares of FHTX stock, worth $234,499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,438Holding current value
$234,499% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FHTX
# of Institutions
83Shares Held
36.3MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$49.2 Million17.9% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$20.6 Million0.94% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.26MShares$12.6 Million0.38% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$8.91 Million0.01% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.03MShares$7.87 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $162M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...